Soft Tissue Sarcoma Program
Early findings suggest CAR-T for solid tumors may advance beyond ‘very nascent stage’ (Healio - July 23, 2024)
CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I trial (Baylor College of Medicine - April 24, 2024)
Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma (Baylor College of Medicine - March 28, 2024)
Proud to be ranked one of the best children’s cancer centers in the country by U.S. News & World Report for seven consecutive years.
Texas Children's Cancer and Hematology Center
Solid Tumor Programs